BM neoplastic disorders Flashcards
Some general BM characteristics found in myeloproliferative neoplasms (MPN)
- Hypercell. & hyper vascular
- MK hyperplasia & dysMKpoeisis
- Haematopoeitic maturation
- Reticulin fibrosis
What would you classify this? (MPN)
- WBC-cytosis (Hi eosin & baso)
- 10% blast
- RBC & plt -paenia
- BM myeloid lineage hyperplasia
- JAK2 mutation neg
- BCR-ABL1 neg
- PCM1-JAK2 pos
- BCR-ABL1 neg = not CML
- PCM1-JAK2 pos => Activates JAK2 kinase => MPN
=> MPN, unclassifiable
Some general BM characteristics found in myelodysplastic syndrome (MDS)
- Variable cellularity
- M:E often dec
- L-shift
- <20% blast
- Dysplastic change in 1/+ cell line (RBC, WBC)
what is ringed sideroblast
Fe on periphery of cell (still in mitochondria & not used up= improper haematopoeisis)
What’s the effects of hypocupremia (Lo Cu)
- Lo Cu bc Hi Zn (bc work competitively)
- Lo Cu = impaired Fe absorption & Fe accumulation (sideroblast & dysplastic changes)
=> reversible pancytopenia w/ dysplastic changes (i.e. not neoplastic MDS)
Effect of RARS-T to RBC/WBC/plt
- RBC: sideroblast, macrocytosis
- plt: -cytosis
Some general BM characteristics found in Acute myeloid leukaemia (AML)
- > 20% blast
- mixed w/ haematopoeitc cells, lympho & plasma cells
- differentiated haematopoeitic cells may exhibit dysplastic features
- hypercellularity
- Granulomas
- Fibrosis
- Reactive plasmocytosis
What are lymphoglandular bodies & what does it mean when found in BM smears
LB: cytoplasmic fragments of cell’s cytoplasm - pale, lightly basophilic & lack granulation (occasional blebs)
- Often associated w/ lymphoid malignancies
Some general BM characteristics found in Acute Lymphoblastic Leukaemia (precursor lymphoid neoplasm)
- > 20% blast
- mixed w/ haematopoeitc cells, lympho & plasma cells
- differentiated haematopoeitic cells w/ NO dysplastic features
What’s the difference b/w B-ALL w/ hyPERdiploidy & B-ALL w/ hyPOdiploidy
- hyPER: multiple chromosomes have extra copies = better prognosis
- hyPO: multiple chrom. have one less copy = poor prognosis
What is Dual & Sequential Haematopoetic Neoplasia (DSHN) & what causes it
• 2 haematopoetic neoplasms (HN) reported in same patient
• in 2% of pts Therapy for one HN may lead to 2nd HN = Therapy-related HN
- usually when using drugs that can affect DNA & processes (e.g. alkylators, inhibitors, ionising radiation)
Describe changes that may occur in the composition of bone marrow and peripheral blood that occur with (combined) non-haematological
and haematological neoplasm (CNHHN)
- severe thombocytopenia
- anaemia
- mild leukocytosis
- BM: 2 population of cells due to 2 different neoplasm (haematopoetic & metastatic neoplasm)